Cargando…
Use of QT Prolonging Medications by Hemodialysis Patients and Individuals Without End‐Stage Kidney Disease
BACKGROUND: The rate of sudden cardiac death in the hemodialysis population exceeds that of the general population by >20‐fold. Hemodialysis patients may be particularly susceptible to sudden cardiac death provoked by drug‐induced QT prolongation because of their substantial cardiovascular diseas...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670513/ https://www.ncbi.nlm.nih.gov/pubmed/32578475 http://dx.doi.org/10.1161/JAHA.120.015969 |